Clinical experience oral sumatriptan placebo-controlled dose-ranging study Oral Sumatriptan Dose-defining Study Group double-blind placebo-controlled multicentre study efficacy tolerability mg sumatriptan selective receptor agonist oral dispersible form acute treatment migraine attacks total patients centres countries efficacy results interim analysis cases Tolerability patients improvement headache severity moderate severe none patients mg sumatriptan mg patients mg sumatriptan patients placebo doses vs placebo Adverse events mild transient dose-related adverse event profile mg sumatriptan similar placebo Overall nausea/vomiting bitter taste common complaints proportion patients due adverse events similar placebo mg sumatriptan treatment groups mg sumatriptan anti-migraine efficacy comparable doses 